Angioplasty and stents treat renal arteries:
This article was originally published in Clinica
Endovascular treatments are as effective as bypass for renovascular hypertension but can be performed at a lower cost, US researchers report in the August edition of Radiology. In a retrospective analysis of 130 patients, researchers at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, found that stenting had the highest success rate at 98%, while angioplasty and bypass both exceeded 90%. However, bypassing cost $15,393 versus $1,402 for angioplasty and $2,573 for stenting. Complication rates were 13%, 16% and 38% for angioplasty, stenting and bypass respectively.
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.